THROMBOTIC MICROANGIOPATHIES
Clinical trials for THROMBOTIC MICROANGIOPATHIES explained in plain language.
Never miss a new study
Get alerted when new THROMBOTIC MICROANGIOPATHIES trials appear
Sign up with your email to follow new studies for THROMBOTIC MICROANGIOPATHIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for iTTP patients: study tests treatment without invasive plasma exchange
Disease control Recruiting nowThis study tests whether a simpler treatment for immune thrombotic thrombocytopenic purpura (iTTP) can work without the standard plasma exchange procedure. Instead, patients receive plasma infusions, immune-suppressing drugs, and a medication called caplacizumab. The goal is to s…
Matched conditions: THROMBOTIC MICROANGIOPATHIES
Phase: NA • Sponsor: University Hospital, Rouen • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New test could unlock precision treatment for deadly clotting disease
Diagnosis Recruiting nowThis study aims to improve how doctors diagnose a rare, life-threatening condition called thrombotic microangiopathy (TMA), which causes blood clots in small vessels and can damage the kidneys and brain. Researchers are testing a new blood test (the HMEC test) to better identify …
Matched conditions: THROMBOTIC MICROANGIOPATHIES
Sponsor: Maastricht University Medical Center • Aim: Diagnosis
Last updated May 17, 2026 02:08 UTC
-
Massive study unlocks secrets of rare blood disease survivors
Knowledge-focused Recruiting nowThis study reviews medical records from over 1,200 people with immune thrombotic thrombocytopenic purpura (iTTP), a rare and life-threatening blood disorder. The goal is to understand long-term health issues like heart disease and how new treatments affect survival. No new treatm…
Matched conditions: THROMBOTIC MICROANGIOPATHIES
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated May 17, 2026 02:02 UTC